gemtuzumab ozogamicin
pfizer,ucb pharmaceuticals
['gemtuzumab', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
gemtuzumab ozogamicin (go) in intermediate risk aml n=113
single center
retrospective needs to be confirmed in larger rct #ash22 
Guidelines, updates, Questions, Meetings in Hematology.